Parametric Portfolio Associates’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $3.02M | Sell |
77,774
-13,819
| -15% | -$536K | ﹤0.01% | 2182 |
|
|
2021
Q4 | $5.36M | Buy |
91,593
+5,105
| +6% | +$299K | ﹤0.01% | 1812 |
|
|
2021
Q3 | $5.13M | Sell |
86,488
-4,199
| -5% | -$249K | ﹤0.01% | 1810 |
|
|
2021
Q2 | $7.87M | Buy |
90,687
+5,910
| +7% | +$513K | ﹤0.01% | 1554 |
|
|
2021
Q1 | $6.99M | Buy |
84,777
+6,037
| +8% | +$498K | ﹤0.01% | 1935 |
|
|
2020
Q4 | $7.16M | Buy |
78,740
+17,450
| +28% | +$1.59M | ﹤0.01% | 1836 |
|
|
2020
Q3 | $2.45M | Buy |
61,290
+3,962
| +7% | +$158K | ﹤0.01% | 2383 |
|
|
2020
Q2 | $1.97M | Sell |
57,328
-3,484
| -6% | -$120K | ﹤0.01% | 2513 |
|
|
2020
Q1 | $1.35M | Buy |
60,812
+38,572
| +173% | +$857K | ﹤0.01% | 2615 |
|
|
2019
Q4 | $435K | Buy |
22,240
+2,130
| +11% | +$41.7K | ﹤0.01% | 3419 |
|
|
2019
Q3 | $312K | Buy |
20,110
+2,847
| +16% | +$44.2K | ﹤0.01% | 3511 |
|
|
2019
Q2 | $350K | Buy |
17,263
+2,763
| +19% | +$56K | ﹤0.01% | 3516 |
|
|
2019
Q1 | $255K | Sell |
14,500
-386
| -3% | -$6.79K | ﹤0.01% | 3622 |
|
|
2018
Q4 | $191K | Buy |
14,886
+2,697
| +22% | +$34.6K | ﹤0.01% | 3672 |
|
|
2018
Q3 | $199K | Sell |
12,189
-1,384
| -10% | -$22.6K | ﹤0.01% | 3764 |
|
|
2018
Q2 | $154K | Sell |
13,573
-81,581
| -86% | -$926K | ﹤0.01% | 3748 |
|
|
2018
Q1 | $929K | Buy |
95,154
+83,120
| +691% | +$812K | ﹤0.01% | 3060 |
|
|
2017
Q4 | $74K | Buy |
+12,034
| New | +$74K | ﹤0.01% | 3847 |
|